Evidence map›Paper›PMID 35217106›Full record

ArticleThe Journal of infection2022

Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant.

Paula de Michelena, Ignacio Torres, Ángela Ramos-García, Victoria Gozalbes, Nidia Ruiz, Ana Sanmartín, Pilar Botija, Sandrine Poujois, Dixie Huntley, Eliseo Albert and 1 more

Open access · greenAbstract readLetter
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Sensitive detection of SARS-CoV-2 main protease 3CLProtein science : a publication of the Protein Society · 2024
    Article
  6. Article
  7. Article
  8. Evaluating Policies to Decrease the Risk of Introducing SARS-CoV-2 Infections to Nursing Home Facilities.Journal of applied gerontology : the official journal of the Southern Gerontological Society · 2023
    Article
  9. Article
  10. Article
  11. Real-life evaluation of a rapid antigen test (DPP SARS-CoV-2 Antigen) for COVID-19 diagnosis of primary healthcare patients, in the context of the Omicron-dominant wave in Brazil.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Article
  12. Article
  13. Article
  14. Aptamer-Based Strategies to Address Challenges in COVID-19 Diagnosis and Treatments.Interdisciplinary perspectives on infectious diseases · 2023
    Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Paula de MichelenaMicrobiology Service, INCLIVA Health Research Institute, Instituto de Investigación INCLIVA, Clinic University Hospital, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
Ignacio TorresMicrobiology Service, INCLIVA Health Research Institute, Instituto de Investigación INCLIVA, Clinic University Hospital, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
Ángela Ramos-GarcíaHealth Department Clínico-Malvarrosa, Health Care Center Benimaclet, Valencia, Spain.
Victoria GozalbesHealth Department Clínico-Malvarrosa, Health Care Center Salvador Pau, Valencia, Spain.
Nidia RuizHealth Department Clínico-Malvarrosa, Health Care Center Serrería, Valencia, Spain.
Ana SanmartínHealth Department Clínico-Malvarrosa, Primary Health Directorate, Valencia, Spain.
Pilar BotijaHealth Department Clínico-Malvarrosa, Primary Health Directorate, Valencia, Spain.
Sandrine PoujoisMicrobiology Service, INCLIVA Health Research Institute, Instituto de Investigación INCLIVA, Clinic University Hospital, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
Dixie HuntleyMicrobiology Service, INCLIVA Health Research Institute, Instituto de Investigación INCLIVA, Clinic University Hospital, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
Eliseo AlbertMicrobiology Service, INCLIVA Health Research Institute, Instituto de Investigación INCLIVA, Clinic University Hospital, Av. Blasco Ibáñez 17, Valencia 46010, Spain.
David NavarroMicrobiology Service, INCLIVA Health Research Institute, Instituto de Investigación INCLIVA, Clinic University Hospital, Av. Blasco Ibáñez 17, Valencia 46010, Spain; Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain. Electronic address: david.navarro@uv.es.
INCLIVA Health Research Institute · ESUniversitat de València · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2HumansImmunologic TestsNucleoproteinsNucleoproteinsCovid-19Field performance studyOmicron variantRapid antigen assaySars-CoV-2

Identifiers

PMID35217106
PMCPMC8863328
OpenAlexW4221038005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.